South Korea Vascular Embolization Market Research Report By Embolization Technique (Coiling Devices, Non-coiling Devices) and By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other)- Forecast to 2035

South Korea Vascular Embolization Market Overview

As per MRFR analysis, the South Korea Vascular Embolization Market Size was estimated at 47.54 (USD Million) in 2023. The South Korea Vascular Embolization Market Industry is expected to grow from 52.25(USD Million) in 2024 to 156.75 (USD Million) by 2035. The South Korea Vascular Embolization Market CAGR (growth rate) is expected to be around 10.503% during the forecast period (2025 - 2035).

Key South Korea Vascular Embolization Market Trends Highlighted

The South Korean Vascular Embolisation Market is experiencing substantial growth, which is being driven by a number of critical market drivers. The demand for advanced medical procedures is on the rise in South Korea due to the ageing population and age-related health complications. In addition, the demand for effective vascular embolisation procedures is increasing due to the increasing prevalence of chronic diseases, including cancer and cardiovascular disorders. Technological advancements are improving the efficacy and safety of these procedures in medical equipment and imaging techniques, which are attracting both clinicians and patients. The integration of minimally invasive techniques and the development of novel embolisation materials that can enhance outcomes are among the opportunities to be investigated in the South Korea market. 

Further opportunities for market participants are presented by the government's dedication to improving healthcare infrastructure and promoting innovative therapies. These opportunities can be effectively leveraged through partnerships with local hospitals and research institutions. In recent years, there has been a rise in patient awareness of the advantages of vascular embolisation, which has resulted in a greater number of individuals seeking these procedures. Additionally, there is an increasing emphasis on the development of specialized training for healthcare professionals to enhance the professional skills necessary for these advanced procedures. 

The future of this market is being influenced by the emphasis on patient-centered care and individualized treatment plans, as clinicians strive to offer customized solutions that cater to the unique requirements of each patient.In general, the South Korean Vascular Embolisation Market is undergoing a rapid transformation, which is being driven by technological advancements, demographic changes, and a distinct transition to more efficient healthcare delivery models.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

South Korea Vascular Embolization Market Drivers

Increasing Incidence of Chronic Diseases

The rising prevalence of chronic diseases such as cancer, arteriovenous malformations, and uterine fibroids significantly drives the South Korea Vascular Embolization Market Industry. According to the Ministry of Health and Welfare of South Korea, chronic diseases accounted for approximately 87.5% of the total disease burden in the country, underlining a substantial healthcare challenge. The Korean Cancer Association reported that the number of new cancer cases was estimated to exceed 240,000 in 2020, showing a consistent annual growth of around 3.1%.This increase in chronic disease cases necessitates innovative treatment solutions, including vascular embolization, indicating a robust growth potential for the market in South Korea. Established medical facilities, such as Samsung Medical Center and Seoul National University Hospital, are increasingly adopting vascular embolization techniques, reinforcing this trend in the healthcare landscape of South Korea.

Technological Advancements in Medical Devices

Advancements in medical technology are substantially propelling the South Korea Vascular Embolization Market. The 2021 National Institute of Health statistics reported a 15% increase in the adoption of minimally invasive procedures facilitated by enhanced medical devices and techniques. This trend is particularly evident in the development of specialized embolization materials, which have been designed to improve efficacy and patient outcomes.South Korean companies like Medtronic and Boston Scientific are pioneering this innovation, contributing to improved precision in vascular embolization processes. As the demand for effective treatment options rises among healthcare providers and patients alike, the integration of advanced technology will further elevate the market growth prospects.

Growing Healthcare Expenditure

The growing healthcare expenditure in South Korea is a pivotal factor driving the South Korea Vascular Embolization Market Industry. According to Statistics Korea, the country’s healthcare spending increased by 6.2% in 2021 compared to the previous year, reaching approximately USD 88.9 billion. This uptick in spending reflects a commitment to enhancing healthcare infrastructure and access to advanced medical treatments. The Korean government has placed significant emphasis on improving healthcare services, as evidenced by its 'Healthy Korea 2030' initiative, which aims to promote preventive healthcare and efficient treatment methodologies. As more funds are allocated towards advanced medical procedures, including vascular embolization, the market is expected to grow robustly, owing to the prioritization of cutting-edge medical solutions.

South Korea Vascular Embolization Market Segment Insights

Vascular Embolization Market Embolization Technique Insights

The Embolization Technique segment within the South Korea Vascular Embolization Market showcases a dynamic landscape influenced by ongoing advancements and changing healthcare needs. Vascular embolization plays a crucial role in treating various vascular conditions, providing an effective intervention for issues such as tumors and vascular malformations. Among the techniques utilized in this field, two categories stand out: Coiling Devices and Non-coiling Devices. Coiling Devices are essential for treating aneurysms, offering a minimally invasive solution that significantly reduces recovery time for patients.

The ability to position these devices precisely within the affected vessels enhances the efficacy of treatments and minimizes complications. On the other hand, Non-coiling Devices include various alternatives such as liquid embolic agents, which have gained traction for their versatility and effectiveness in anatomical variations where traditional coiling might be less beneficial. The market dynamics are driven by increasing awareness of vascular disorders and the demand for less invasive surgical options. Additionally, demographic factors such as an aging population in South Korea contribute to the rise in vascular conditions, thereby elevating the need for reliable embolization techniques.

Furthermore, ongoing technological innovations and Research and Development investments in both Coiling and Non-coiling Devices continue to expand treatment capabilities, ensuring better patient outcomes. In urban settings, advanced healthcare infrastructure amplifies access to innovative treatment options, driving the adoption of these Embolization Techniques. Ultimately, the South Korea Vascular Embolization Market is characterized by a strong push towards enhancing procedural efficiency and patient safety through enhanced device functionalities and individualized treatment regimens.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review

Vascular Embolization Market Application Insights

The Application segment of the South Korea Vascular Embolization Market plays a crucial role in addressing various health challenges within the region. This segment encompasses several areas such as Peripheral Vascular Disease, Oncology, Neurology, Urology, and other applications, each contributing significantly to the market dynamics. Peripheral Vascular Disease is a notable component, as it reflects a growing incidence of circulatory disorders in South Korea, driven by factors like an aging population and lifestyle diseases. The Oncology segment is gaining traction due to the rising number of cancer cases, making embolization a critical treatment option for tumor control and management.

Neurology applications stand out for their importance in treating conditions like arteriovenous malformations, which enhances patient outcomes through minimally invasive procedures. Urology is also significant as vascular embolization offers innovative approaches for treating renal tumors and bleeding, reducing patient recovery times and risks. Overall, the segmentation reflects the diverse medical landscape of South Korea, where increased awareness and advancements in medical technology are accelerating market growth, providing new opportunities for effective interventions in healthcare.

South Korea Vascular Embolization Market Key Players and Competitive Insights

The South Korea Vascular Embolization Market is characterized by a dynamic environment that reflects the growing demand for advanced medical technologies and procedures aimed at treating various vascular conditions. The market has experienced considerable growth due to increasing awareness of embolization therapies, technological advancements, and a rise in the number of procedures performed. As healthcare providers focus on improving patient outcomes and optimizing treatment options, competitive dynamics are continually reshaping the market landscape. Key players are investing in research and development to introduce innovative products, while also engaging in strategic partnerships and collaborations. 

The increasing prevalence of chronic diseases and an aging population in South Korea are further driving the necessity for effective vascular treatments, leading to heightened competition and the emergence of new entrants in the market.AngioDynamics has successfully established a strong presence in the South Korea Vascular Embolization Market by leveraging its reputation for providing high-quality medical devices and solutions. The company is particularly noted for its emphasis on innovation, which is evident in its product offerings that cater to various embolization needs. The strength of AngioDynamics lies in its comprehensive understanding of the local healthcare landscape, enabling it to effectively address the specific requirements of South Korean patients and healthcare professionals. 

Additionally, AngioDynamics often relies on gathering feedback directly from clinicians to enhance its product lines and streamline functionalities, positioning itself as a trusted partner among vascular specialists. This focus on customer service and product education contributes significantly to the company's competitive advantage in South Korea.Asahi Intecc has carved out a notable segment of the South Korea Vascular Embolization Market, focusing on advanced catheter technologies and other specialized medical devices. The company is widely recognized for its high-quality guidewires and catheter products specifically designed for minimally invasive procedures. Asahi Intecc's strengths include a strong commitment to research and development, facilitating the continuous introduction of cutting-edge products that resonate with the needs of medical professionals in South Korea. 

The company has maintained a solid market presence through strategic collaborations with local healthcare providers, enhancing its distribution capabilities. Recent mergers and acquisitions have also bolstered Asahi Intecc's competitive positioning, allowing the company to expand its product portfolio and enter new market segments. These strategies help reinforce its reputation as a leader in vascular embolization solutions, making it a significant player within the South Korean healthcare landscape.

Key Companies in the South Korea Vascular Embolization Market Include

• AngioDynamics


• Asahi Intecc


• Johnson & Johnson


• Guerbet


• Abbott Laboratories


• Hologic


• Terumo


• Boston Scientific


• B. Braun


• Medtronic


• Stryker


• Cardinal Health


• Cook Medical


• Merit Medical Systems


• Ceremed

South Korea Vascular Embolization Market Industry Developments

The South Korea Vascular Embolization Market has witnessed significant recent developments, particularly in the domains of technology and strategic movements. Companies such as AngioDynamics and Johnson and Johnson are focusing on advanced embolization techniques, enhancing the effectiveness of treatment options. In March 2023, Meritor, now acquired by BorgWarner, announced entering into collaborative agreements with Boston Scientific to expand accessibility of vascular embolization devices across various healthcare settings in South Korea. 

The market has observed growth in valuation, primarily driven by the increasing prevalence of vascular diseases and the rising demand for minimally invasive procedures. Major players, including Abbott Laboratories and Terumo, have experienced a surge in product demand due to technological advancements and improved healthcare infrastructure. In the past two to three years, significant innovations, such as Hologic's enhanced imaging systems and Guerbet's new contrast agents, have further galvanized market interests. The South Korean government's continued investment in healthcare research and development is expected to bolster the Vascular Embolization sector's growth trajectory, signifying a robust future for both domestic and global players in this market.

South Korea Vascular Embolization Market Segmentation Insights

Vascular Embolization Market Embolization Technique Outlook

• Coiling Devices


• Non-coiling Devices

Vascular Embolization Market Application Outlook

• Peripheral Vascular Disease


• Oncology


• Neurology


• Urology


• Other

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	47.54(USD Million)
MARKET SIZE 2024	52.25(USD Million)
MARKET SIZE 2035	156.75(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	10.503% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	AngioDynamics, Asahi Intecc, Johnson & Johnson, Guerbet, Abbott Laboratories, Hologic, Terumo, Boston Scientific, B. Braun, Medtronic, Stryker, Cardinal Health, Cook Medical, Merit Medical Systems, Ceremed
SEGMENTS COVERED	Embolization Technique, Application
KEY MARKET OPPORTUNITIES	Growing demand for minimally invasive procedures, Increasing prevalence of vascular diseases, Advancements in embolization technologies, Expanding healthcare infrastructure investments, Rising awareness and training programs
KEY MARKET DYNAMICS	Increasing incidence of vascular diseases, Advancements in embolization technologies, Growing demand for minimally invasive procedures, Rise in geriatric population, Expanding applications in oncology
COUNTRIES COVERED	South Korea